亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial

医学 恶化 慢性阻塞性肺病 危险系数 内科学 强的松 优势比 置信区间 慢性阻塞性肺疾病急性加重期
作者
Brigitte Engel,Christian Schindler,Jörg D. Leuppi,Jonas Rutishauser
出处
期刊:Schweizerische Medizinische Wochenschrift 卷期号:147 (1920) 被引量:9
标识
DOI:10.4414/smw.2017.14439
摘要

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) compromise physical activity and quality of life and contribute significantly to health care costs. Systemic glucocorticoids benefit clinical outcome in AECOPD, and the REDUCE trial demonstrated noninferiority of a 5-day treatment course with prednisone compared with 14 days therapy regarding clinical outcome over 6 months of follow-up. Unexpectedly, we found an inverse correlation between circulating cortisol levels and exacerbation risk during a 6-month follow-up period.To evaluate whether additional predictors of COPD re-exacerbation can be identified after the index exacerbation in the REDUCE cohort.Of 314 patients with AECOPD randomised to 5 or 14 days of prednisone treatment, 311 were included in the analysis. Parameters tested as predictors of re-exacerbation were sex, age, smoking status, forced expiratory volume in one second (FEV1), dyspnoea as assessed with the Medical Research Council (MRC) dyspnoea scale, home oxygen therapy, pretreatment with systemic glucocorticoids, pretreatment with antibiotics, duration of hospitalisation, blood pressure, oxygen saturation, admission to the Intensive Care Unit (ICU) and relevant infections in follow-up. The risks for re-exacerbation were estimated by means of logistic regression and Cox proportional hazard models and expressed as odds ratios and hazard ratios, respectively.After multivariate adjustment, significant predictors at hospital discharge for COPD re-exacerbation during follow-up were: duration of hospital stay >8 days (hazard ratio [HR] 1.54, 95% confidence interval [CI] 1.03-2.28); FEV1 <30% predicted (HR 1.76, 95% CI 1.06-2.91); hypertension (HR 2.39, 95% CI 1.04-5.48) and MRC dyspnoea scale (HR 1.61, 95% CI 1.30-2.01, per unit increment). Present cigarette smoking (HR 0.60, 95% CI 0.38-0.92) was negatively associated with re-exacerbation.In addition to biochemical suppression of the adrenal glands, other standard clinical parameters predict re-exacerbation in patients admitted to the emergency department with AECOPD. (REDUCE trial registration: ISRCTN29646069).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Aurora完成签到 ,获得积分10
刚刚
Hello应助hsr_eye采纳,获得10
4秒前
123发布了新的文献求助10
21秒前
linshunan完成签到 ,获得积分10
26秒前
就叫希望吧完成签到 ,获得积分10
27秒前
mhq完成签到 ,获得积分20
31秒前
量子星尘发布了新的文献求助10
50秒前
1分钟前
吴嘉俊完成签到 ,获得积分10
1分钟前
Joeswith完成签到,获得积分10
1分钟前
杨怂怂完成签到 ,获得积分10
1分钟前
风雨中飘摇应助科研通管家采纳,获得200
1分钟前
1分钟前
Chris完成签到 ,获得积分0
1分钟前
zoe完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
大个应助CNS_Fighter88采纳,获得10
1分钟前
轻松的惜芹完成签到,获得积分10
1分钟前
howgoods完成签到 ,获得积分10
1分钟前
1分钟前
Kashing完成签到,获得积分10
2分钟前
CNS_Fighter88发布了新的文献求助10
2分钟前
2分钟前
l123完成签到,获得积分10
2分钟前
CYC完成签到 ,获得积分10
2分钟前
zhao完成签到 ,获得积分10
2分钟前
脑洞疼应助l123采纳,获得10
2分钟前
大个应助守仁则阳明采纳,获得10
2分钟前
2分钟前
木有完成签到 ,获得积分10
2分钟前
2分钟前
科研通AI5应助10 g采纳,获得10
2分钟前
Zoe发布了新的文献求助30
2分钟前
2分钟前
Zoe完成签到,获得积分10
2分钟前
糖伯虎完成签到 ,获得积分10
2分钟前
量子星尘发布了新的文献求助10
2分钟前
2分钟前
l123发布了新的文献求助10
2分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976608
求助须知:如何正确求助?哪些是违规求助? 3520700
关于积分的说明 11204542
捐赠科研通 3257350
什么是DOI,文献DOI怎么找? 1798716
邀请新用户注册赠送积分活动 877881
科研通“疑难数据库(出版商)”最低求助积分说明 806613